| Neil Mundy | Interim Joint Chairman to 31stJuly 2021 |
|||||
|---|---|---|---|---|---|---|
| Derek Bell | Joint Chairman from 1stSeptember 2021 |
|||||
| Julie Ann Gillon | Chief Executive | |||||
| Anandapuram | Deepak Dwarakanath | Medical Director /Deputy Chief Executive |
||||
| Alan Sheppard | Chief People Officer | |||||
| Neil Atkinson | Director ofFinance | |||||
| Graham Evans Lynne Taylor |
Chief Information Technology Otficer Director of Planning 8 Performance to 31stOctober 2021 |
|||||
| Barbara Bright |
Director ofCorporate Affairs and Chief ofStaffto 31st |
March 2022 | ||||
| Levi Buckley | Chief Operating Officer |
|||||
| Stephen Hall |
Vice Chairman and Non-executive Director |
|||||
| Rite Taylor | Non-executive Director to 28th February 2022 |
|||||
| Jonathan Erskine |
Non-executive Director to 28th February 2022 |
|||||
| Kevin Robinson | Non-executive Director to 28th February 2022 |
|||||
| Philip Craig | Non-execulive Director lo 28th February 2022 |
|||||
| Ann Baxter | Non-executive Director |
|||||
| Neil Schneider | Associate Non-executive Director to 14th April 2021 |
|||||
| Lindsey Robertson | Director of Nursing, Patient Safety and Duality |
|||||
| Linda Hunter | Interim Director of Planning 6Pedormance from 1stOctober 2021 |
|||||
| Graham Walton |
Non-executive Director from 1st March 2022 |
|||||
| Christopher Macklin |
Non-executive Director from 24th March 2022 |
|||||
| The Executive | Directors | and Non-executive Directors ofthe Foundation Trust Board are the Trustee of the Charily. |
||||
| The Executive |
Directors | are appointed | by the Non-executive Directors and the Governors |
appoint | the | Non- |
| executive Directors. |
| ~Edi | E000 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Paxman | cooling caps to prevent | hair loss during chemotherapy | treatment | 35 | |||||
| Ornnicell | cabinet drugs dispenser | 33 | |||||||
| Motomed | letto2 leg/arm bed |
model | ITU | 10 | |||||
| Mammography | biopsy mobile | chair | 7 | ||||||
| Portable | hand | held saturation | monitors, | leads &probes Neonatal | 6 | ||||
| Duo headlight | breast unit | 5 | |||||||
| Other medical | equipment | ||||||||
| 107 |
| jor refurbishments a |
nd IT equipme | nt purchases during the |
year are shown | below: | ||
|---|---|---|---|---|---|---|
| ~E* | dtt | EDOD | ||||
| HL7 Reporting interface between |
ICE & Unisoft Endoscopy | System | 10 | |||
| Brainomix - Software | 9 | |||||
| Other refurbishment | costs | |||||
| 22 |
| ~E* | dt | EDOD | ||||||
|---|---|---|---|---|---|---|---|---|
| Staff | training | 35 | ||||||
| Staff | recharge | room equipment, | external | work and garden | furniture | 17 | ||
| Other | staff welfare | 17 | ||||||
| 70 |
| ~E* | dtt | EODD | ||||
|---|---|---|---|---|---|---|
| Staff lottery | winnings | paid | 27 | |||
| Staff lottery | administration | costs | 1 | |||
| Fundraising | Events | costs | 5 | |||
| Fundraising | salary recharge costs | 22 | ||||
| 55 |
| Statement ofFinancia | l Ac |
tivi | ties for the ye | ar ended | 31 March 2022 | |||
|---|---|---|---|---|---|---|---|---|
| Total | Total | |||||||
| Note | Unrestricted | Restricted | Funds | Funds | ||||
| Funds | Funds | 2021/22 | 2020/21 | |||||
| E000 | E000 | 6000 | EOOO | |||||
| Income and endowments | from: | |||||||
| Donations | 3 | 398 | 100 | 498 | 547 | |||
| Legacies | 3 | 161 | 161 | 16 | ||||
| Charitable activities |
4 | 41 | 41 | 20 | ||||
| Other trading activities-staff |
lottery | 5 | 40 | 43 | 17 | |||
| Other incoming resources |
6 | 5 | 5 | 66 | ||||
| Investment Income |
13.3 | 20 | 21 | 41 | 40 | |||
| Total incoming resources |
582 | 207 | 789 | 706 | ||||
| Expenditure on: |
||||||||
| Raising Funds | 26 | 29 | 55 | 12 | ||||
| Charitable activities: |
||||||||
| Research Posts and Clinical | Care | 4 | 4 | 29 | ||||
| Purchase of Equipment |
107 | 107 | 143 | |||||
| Refurbishment costs |
22 | 22 | 38 | |||||
| Staff Education and Welfare |
18 | 52 | 70 | 178 | ||||
| Patient Welfare | 4 | 37 | 41 | 10 | ||||
| Governance Costs |
18 | 19 | 37 | 37 | ||||
| Total expenditure | 66 | 270 | 336 | 447 | ||||
| Net gain on investments | 13.1 | 56 | 62 | 118 | 233 | |||
| Net income/(expenditure) | before transfers | 572 | (1) | 571 | 492 | |||
| Transfers between funds |
16 | 4 | (4) | |||||
| h/et movement in funds |
18 | 576 | (5) | 571 | 492 | |||
| Fund balances brought |
forward | at 1 April 2021 | 816 | 1,230 | 2,046 | 1,554 | ||
| Fund balances carried | forward at 31 Nlerch 2022 | 1,392 | 1,225 | 2,617 | 2,046 | |||
| All gains and losses recognised | in the year are | included | in the above statement. | |||||
| All amounts relate to continuing |
operations. | |||||||
| The notes at pages 18 | to 27 | form part ofthese | financial | statements. |
| Balance Sheet as | at 31 INarch 2022 | |||||
|---|---|---|---|---|---|---|
| Note | Unrestrided | Restricted | Total at 31 | Total at 31 | ||
| Funds | Funds | March 2022 | March 2021 | |||
| 8000 | 7000 | 6000 | 0000 | |||
| Fixed Assets | ||||||
| Investments | 13 | 726 | 743 | 1.469 | 1,351 | |
| Total fixed assets | 726 | 743 | 1,469 | 1,351 | ||
| Currant Assets | ||||||
| Debtors and accrued income | 0 | 12 | 12 | 280 | ||
| Cash and cash equivalents | 667 | 580 | 1,247 | 520 | ||
| Total currenl assets | 667 | 592 | 1,259 | 800 | ||
| Current liabilities |
||||||
| Creditors: Amounts | falling due | |||||
| within one year | 15 | 110 | 105 | |||
| Net current assets | 666 | 482 | 1,148 | 695 | ||
| Total assets less current liabilities | 1,392 | 1,225 | 2,617 | 2,046 | ||
| Net Assets | 1.392 | 1,225 | 2,617 | 2,046 | ||
| The funds ofthe Charity | ||||||
| Restncted income funds |
1,225 | 1,225 | 1,230 | |||
| Unrestricted income |
funds | 1,392 | 1,392 | 816 | ||
| Total Charity Funds | 19 | 1,392 | 1.225 | 2.617 | 2.D46 |
| Note | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021/22 | 2020/21 | ||||||||
| f000 | fODD | ||||||||
| Cash flows from operating | activities: | ||||||||
| hist cash used in operating | activities | 16 | 686 | 25 | |||||
| Cash flows from investing | activities: | ||||||||
| Dividends | and interest from | investments | 13.3 | 41 | 40 | ||||
| Proceeds | from sale ofinvestments | ||||||||
| Net cash | provided by investing activities |
4D | |||||||
| Change | in cash and cash | equivalents | in the reporting | pedod | 727 | 65 | |||
| Increase | in cash and cash equivalents | in the year | 727 | 65 | |||||
| Cash and | cash equivalents | at the beginning | of | ||||||
| reporting | period | 520 | 455 | ||||||
| Total cash and cash equivalents at the end |
1,247 | 520 | |||||||
| ofthe year |
| Unrestricted | Restricted | Total | Total | |||
|---|---|---|---|---|---|---|
| Funds | Funds | 2021/22 | 2020/21 | |||
| EOOD | EOOD | EOOO | EOOO | |||
| Donations | 5 | 86 | 91 | 81 | ||
| Fundraising | Income Generated | by Individuals | 6 | 8 | 14 | 30 |
| Grants Receivable | 25 | 2 | 27 | 173 | ||
| Corporate | Donations | 361 | 1 | 362 | 257 | |
| Gift Aid | 1 | 3 | 4 | 6 | ||
| Legacies | 161 | 161 | 16 | |||
| Tots I | 559 | 100 | 659 | 563 |
| Unrestricted | Restricted | Total | Total | |||
|---|---|---|---|---|---|---|
| Funds | Funds | 2021/22 | 2020/21 | |||
| EOOO | EOOO | EOOO | EOOO | |||
| Income from | the provision | |||||
| ofeducation | and training | 41 | 41 | 20 | ||
| Total | 41 | 41 | 20 | |||
| 5.Other Trading Activities | ||||||
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | 2021/22 | 2020/21 | |||
| EOOO | EOOO | EOOO | EOOO | |||
| Staff Lottery | deductions | 40 | 40 | 17 | ||
| Fundraising | Events | 3 | ||||
| Total | 40 | 43 | 17 | |||
| 6. Other Incoming | Resources | |||||
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | 2021/22 | 2020/21 | |||
| EOOO | EOOO | EOOO | EOOO | |||
| Other Income | 5 | 5 | 66 | |||
| Total | 5 | 66 |
| 7.Raising | Funds | |||
|---|---|---|---|---|
| 2021/22 | 2020/21 | |||
| 6000 | EOOO | |||
| Staff Lottery | Winnings | & Admin | 28 | 12 |
| Fundraising | Expenses | 5 | ||
| Fundraising | Salary Costs | 22 | ||
| Total | 55 | 12 |
| 8.Charitable activit |
8.Charitable activit |
8.Charitable activit |
ies | |||||
|---|---|---|---|---|---|---|---|---|
| The Charity pursued | its charitable | activities | by making | grants, | shown | below by category. | ||
| 2021/22 | 2020/21 | |||||||
| EOOO | 6000 | |||||||
| Purchase | of Equipment | 107 | 143 | |||||
| Research | Posts | and | Clinical Care | 4 | 29 | |||
| Refurbishment Costs & IT Equipment |
22 | 38 | ||||||
| Staff Education | and Welfare | 70 | 178 | |||||
| Patients | Welfare | 41 | 10 | |||||
| Total | 398 |
| 13.1 Movement in |
fixed asset | fixed asset | fixed asset | fixed asset | investment | 2021/22 | 2020/21 | |
|---|---|---|---|---|---|---|---|---|
| Total | Total | |||||||
| EOOD | EOOD | |||||||
| hllarket value brought |
forward | 1,351 | 1,118 | |||||
| Monies owed by CCLA for | Chanaes | 10 | 10 | |||||
| Short term dividends | (10) | (10) | ||||||
| Less disposals at carrying |
value | |||||||
| Net gain on revaluation | 118 | 233 | ||||||
| Market value at 31 | March | 1,489 | 1,351 | |||||
| 13.2 Market value at | 31 March | 2021/22 | 2020/21 | |||||
| Total | Total | |||||||
| EOOD | EOOD | |||||||
| Held in UK | ||||||||
| COIF Charities Investment |
Fund | 1,469 | 1,351 | |||||
| Total | 1,469 | 1,351 | ||||||
| The COIF Charities | Investment | Fund includes | the following | investments: | ||||
| 2021/22 | 2020/21 | |||||||
| Asset agocation | ||||||||
| Overseas Equities |
64.13% | 67.23% | ||||||
| Infrastructure & Operating |
Assets | 9.06% | 9.12% | |||||
| Cash &near cash | 8.52% | 4.83% | ||||||
| UK Equities | 850% | 989% | ||||||
| Property | 4.58% | 3.90% | ||||||
| Contractual & Other |
income | 2.76% | 2.68% | |||||
| Private Equity & Other | 245% | 20lo%%do | ||||||
| Fixed Interest | 0.34% |
| 13.3 Total gross income from invest | ments and cash on deposit |
|
|---|---|---|
| 2021/22 | 202D/21 | |
| Tote I | Total | |
| EOOD | ROOD | |
| Held in UK | ||
| Investments | 41 | |
| Total | 41 | 40 |
| 14.Deb | tors | : | amou | nts | falling du | e within | one year | one year | |
|---|---|---|---|---|---|---|---|---|---|
| 2021/22 | 2020/21 | ||||||||
| Total | Total | ||||||||
| RDDO | EOOD | ||||||||
| Dividend | Income | 11 | 10 | ||||||
| Prepayments | 1 | 4 | |||||||
| Accrued | Income | 266 | |||||||
| Total | 280 | ||||||||
| 15.Creditors: | amounts | falling due wtthin | one year | ||||||
| 2021/22 | 2020/21 | ||||||||
| Total | Total | ||||||||
| EODO | EOOD | ||||||||
| Accruals | 81 | 64 | |||||||
| Deferred | Income | 4 | 9 | ||||||
| Amounts | owed | to hforth | Tees and | Hartlepool | NHS | 18 | 32 | ||
| Foundation | Trust | ||||||||
| Other creditors | |||||||||
| Total | 1D5 | ||||||||
| There is | no | security | for | non-trading | amounts | owed to the Foundation | Trust. | ||
| 16. Transfers | between | funds | 202'I/22 | 2020/21 | |||||
| Total | Total | ||||||||
| EOOD | ROOD | ||||||||
| Transfers |
| 2021/22 | 2020/21 | ||||
|---|---|---|---|---|---|
| Total | Total | ||||
| 6000 | OOOO | ||||
| Net movement in funds |
571 | 492 | |||
| Gain on investments | (118) | (233) | |||
| Deduct interest/dividends | income shown | ||||
| in investing activities |
(41) | (40) | |||
| Decrease/(Increase) | in debtors | 268 | (266) | ||
| increase in creditors |
6 | 72 | |||
| Net cash generated | from | operating | activities | 686 | 25 |
| Annuai Report | Annuai Report | Annuai Report | Annuai Report | Annuai Report | and Accounts for North Tees | and Accounts for North Tees | and | Hart(spoof | NHS Foundal!on | NHS Foundal!on | NHS Foundal!on | NHS Foundal!on | Trust | Trust | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General | Charitable | Fund | |||||||||||||||||||||
| lit. Analysis | of | Charitable | Funds | ||||||||||||||||||||
| Adjustment | for | ||||||||||||||||||||||
| balance | |||||||||||||||||||||||
| movemenl | of | ||||||||||||||||||||||
| uOnlatrlotild | furnla | ||||||||||||||||||||||
| underandover | |||||||||||||||||||||||
| Fund Balances | 625,0DO | Incomilng | Resources | Irllemal | Fund Balances | ||||||||||||||||||
| at 31 March 2021 | at 31 March | 2021 | Resources | Expended | Transfers | at 31 March 2D22 | |||||||||||||||||
| OsSCnpnOnOrthe St meodpurpmesrme |
|||||||||||||||||||||||
| ll~iiw | fund | 6000 | EODO | Eoao | 6000 | 6000 | r.DDO | ||||||||||||||||
| Funds over | a5,000 | ||||||||||||||||||||||
| Tc SuPPOrl Patiem Care Wchln Ihe ClreCtarate | |||||||||||||||||||||||
| I | Me maria l | Fund | (cur | geiy | ) | of Surgery | 51 | (3) | 52 | ||||||||||||||
| Tosuppon pauent care within breast service | |||||||||||||||||||||||
| 2 Breast Surgery | Fund | indudlng | equipmenl 8 Iralning |
75 | (15) | 66 | |||||||||||||||||
| To support | patient care (or individuals | requinng | |||||||||||||||||||||
| 3Speal Fund | treatment | vnthm Ihe Spnat Ceparlmenl | 48 | 50 | |||||||||||||||||||
| To support | patient cars fw Indivnlua le |
vnlh | |||||||||||||||||||||
| 4 | Haemalology | Fund | blaod disorders | 124 | (3S) | I0D | |||||||||||||||||
| To suppod | paOenl care For indiwdua le |
||||||||||||||||||||||
| 5 | UrologyResearchFund | dragnosed | with Urology/Krdneyrelaledillnets | 36 | 40 | ||||||||||||||||||
| 6 | iMLegacy | Fund | To sup perl the purchase ofequip ment benefit ol cancer patients |
fer Ihe | 153 | 16 | (17) | 152 | |||||||||||||||
| To supped | palienl care for indiwduals | requmng | |||||||||||||||||||||
| 7 | Cardiology | Fu4d | treatment | vnthln the Cardiac unit |
116 | 14 | (4) | 126 | |||||||||||||||
| Tosupped | patient care tor in Civduels |
requiring | |||||||||||||||||||||
| a | Neo.Natal | treatment | within lhe neo-nels( unit |
28 | (27) | 12 | |||||||||||||||||
| To support | atm ke patients weaare and |
staff | |||||||||||||||||||||
| 9 | Stroke Fund | training | 43 | (17) | |||||||||||||||||||
| To support | Coloredel patient servces, |
staff | |||||||||||||||||||||
| lo | Cnlcredal | Carioer Furid | EduCalinn | 6 Trasling | 30 | 31 | |||||||||||||||||
| il | hleonalal Life |
Supporl | SupporlrunningofLife Support course |
41 | 12 | lgl | 44 | ||||||||||||||||
| Breasl Canrar nurae trainmg IVuelt*ra | ll | ||||||||||||||||||||||
| tz | Breast Care Nurwng | Fund | hardship fund for patients |
ee | 13 | il8) | 71 | ||||||||||||||||
| To support | patient care for individuals | requlhmg | |||||||||||||||||||||
| 13 | Chematherapy | Fund | treatment wilhm Chemotherapy Fund UHNT |
53 | GD) | 21 | |||||||||||||||||
| Funds Increased | to | above | 525,000exat 31 March 2D22 | ||||||||||||||||||||
| 14 | Music v Cancer | 24 | 2 | (I) | 25 | ||||||||||||||||||
| Removed funds | decreased | to below | f25 005as at 31 March 2022 | ||||||||||||||||||||
| To suppart | pedant care (ar individuals | ||||||||||||||||||||||
| requiring lrealmenl wilhla the neo.nate! |
|||||||||||||||||||||||
| Neo-Natal | snit | (2ei | (II) | 27 | (12) | ||||||||||||||||||
| TO SuPPOn | Patient Care far indiVidus IS requ turn 9 |
||||||||||||||||||||||
| Chemotherapy | Fund | treatment within Chemotherapy Fund UHNT |
(53) | (7) | 39 | i21) | |||||||||||||||||
| Funds at 31 March |
2022 | 866 | (57) | 85 | (113) | 791 | |||||||||||||||||
| Other Funds |
balances | less | than 525 000as at 31stIrtarch 2022 | 57 | 174 | (157) | (4) | ||||||||||||||||
| Total Restricted |
Funds | I 230 | 269 | 270 | 1 225 | ||||||||||||||||||
| Total Unreslncled | Funds | 816 | (66) | 4 | 1,392 | ||||||||||||||||||
| Toter Fund | balances | at31 | March 2022 | 2,046 | 907 | 336l | 2,517 |